Abstract
We present a retrospective series of the clinical and MRI findings in 16 patients with intramedullary spinal sarcoidosis (ISS), including 12 patients studied with gadolinium-DTPA. The spectrum of MRI findings includes leptomeningeal enhancement, fusiform spinal cord enlargement, focal or diffuse intramedullary disease, and spinal cord atrophy. We present a classification of ISS correlating the clinical progression and the temporal sequence of MRI abnormalities. Improvement occurred in five of 12 patients (42%) treated with immunosuppressive therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 333-337 |
Number of pages | 5 |
Journal | Neurology |
Volume | 43 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1993 |
ASJC Scopus subject areas
- Clinical Neurology